Skip to main content
placeholder image

Real-time high spatial resolution dose verification in stereotactic motion adaptive arc radiotherapy

Journal Article


Abstract


  • Purpose: Radiation treatments delivered with real-time multileaf collimator (MLC) tracking currently lack fast pretreatment or real-time quality assurance. The purpose of this study is to test a 2D silicon detector, MagicPlate-512 (MP512), in a complex clinical environment involving real-time reconfiguration of the MLC leaves during target tracking. Methods: MP512 was placed in the center of a solid water phantom and mounted on a motion platform used to simulate three different patient motions. Electromagnetic target tracking was implemented using the Calypso system (Varian Medical Systems, Palo Alto, CA, USA) and an MLC tracking software. A two-arc VMAT plan was delivered and 2D dose distributions were reconstructed by MP512, EBT3 film, and the Eclipse treatment planning system (TPS). Dose maps were compared using gamma analysis with 2%/2 mm and 3%/3 mm acceptance criteria. Dose profiles were generated in sup-inf and lateral directions to show the agreement of MP512 to EBT3 and to highlight the efficacy of the MLC tracking system in mitigating the effect of the simulated patient motion. Results: Using a 3%/3 mm acceptance criterion for 2D gamma analysis, MP512 to EBT3 film agreement was 99% and MP512 to TPS agreement was 100%. For a 2%/2 mm criterion, the agreement was 95% and 98%, respectively. Full width at half maximum and 80%/20% penumbral width of the MP512 and EBT3 dose profiles agreed within 1 mm and 0.5 mm, respectively. Patient motion increased the measured dose profile penumbral width by nearly 2 mm (with respect to the no-motion case); however, the MLC tracking strategy was able to mitigate 80% of this effect. Conclusions: MP512 is capable of high spatial resolution 2D dose reconstruction during adaptive MLC tracking, including arc deliveries. It shows potential as an effective tool for 2D small field dosimetry and pretreatment quality assurance for MLC tracking modalities. These results provide confidence that detector-based pretreatment dosimetry is clinically feasible despite fast real-time MLC reconfigurations.

UOW Authors


  •   Duncan, Mitchell (external author)
  •   Newall, Matthew (external author)
  •   Caillet, Vincent (external author)
  •   Booth, Jeremy T. (external author)
  •   Keall, Paul J. (external author)
  •   Lerch, Michael
  •   Perevertaylo, Vladimir L. (external author)
  •   Rosenfeld, Anatoly B.
  •   Petasecca, Marco

Publication Date


  • 2018

Citation


  • Duncan, M., Newall, M. K., Caillet, V., Booth, J. T., Keall, P. J., Lerch, M., Perevertaylo, V., Rosenfeld, A. B. & Petasecca, M. (2018). Real-time high spatial resolution dose verification in stereotactic motion adaptive arc radiotherapy. Journal of Applied Clinical Medical Physics, 19 (4), 173-184.

Scopus Eid


  • 2-s2.0-85049651049

Number Of Pages


  • 11

Start Page


  • 173

End Page


  • 184

Volume


  • 19

Issue


  • 4

Place Of Publication


  • United States

Abstract


  • Purpose: Radiation treatments delivered with real-time multileaf collimator (MLC) tracking currently lack fast pretreatment or real-time quality assurance. The purpose of this study is to test a 2D silicon detector, MagicPlate-512 (MP512), in a complex clinical environment involving real-time reconfiguration of the MLC leaves during target tracking. Methods: MP512 was placed in the center of a solid water phantom and mounted on a motion platform used to simulate three different patient motions. Electromagnetic target tracking was implemented using the Calypso system (Varian Medical Systems, Palo Alto, CA, USA) and an MLC tracking software. A two-arc VMAT plan was delivered and 2D dose distributions were reconstructed by MP512, EBT3 film, and the Eclipse treatment planning system (TPS). Dose maps were compared using gamma analysis with 2%/2 mm and 3%/3 mm acceptance criteria. Dose profiles were generated in sup-inf and lateral directions to show the agreement of MP512 to EBT3 and to highlight the efficacy of the MLC tracking system in mitigating the effect of the simulated patient motion. Results: Using a 3%/3 mm acceptance criterion for 2D gamma analysis, MP512 to EBT3 film agreement was 99% and MP512 to TPS agreement was 100%. For a 2%/2 mm criterion, the agreement was 95% and 98%, respectively. Full width at half maximum and 80%/20% penumbral width of the MP512 and EBT3 dose profiles agreed within 1 mm and 0.5 mm, respectively. Patient motion increased the measured dose profile penumbral width by nearly 2 mm (with respect to the no-motion case); however, the MLC tracking strategy was able to mitigate 80% of this effect. Conclusions: MP512 is capable of high spatial resolution 2D dose reconstruction during adaptive MLC tracking, including arc deliveries. It shows potential as an effective tool for 2D small field dosimetry and pretreatment quality assurance for MLC tracking modalities. These results provide confidence that detector-based pretreatment dosimetry is clinically feasible despite fast real-time MLC reconfigurations.

UOW Authors


  •   Duncan, Mitchell (external author)
  •   Newall, Matthew (external author)
  •   Caillet, Vincent (external author)
  •   Booth, Jeremy T. (external author)
  •   Keall, Paul J. (external author)
  •   Lerch, Michael
  •   Perevertaylo, Vladimir L. (external author)
  •   Rosenfeld, Anatoly B.
  •   Petasecca, Marco

Publication Date


  • 2018

Citation


  • Duncan, M., Newall, M. K., Caillet, V., Booth, J. T., Keall, P. J., Lerch, M., Perevertaylo, V., Rosenfeld, A. B. & Petasecca, M. (2018). Real-time high spatial resolution dose verification in stereotactic motion adaptive arc radiotherapy. Journal of Applied Clinical Medical Physics, 19 (4), 173-184.

Scopus Eid


  • 2-s2.0-85049651049

Number Of Pages


  • 11

Start Page


  • 173

End Page


  • 184

Volume


  • 19

Issue


  • 4

Place Of Publication


  • United States